ICU Medical CFO Sells 6,381 Shares for $1.1 Million

ICU Medical CFO Brian Michael Bonnell sold 6,381 shares of the company's stock on September 1, 2026, for a total of $1.1 million. This transaction was executed in accordance with a Rule 10b5-1 trading plan that Bonnell had put in place on June 1, 2026, to schedule his share sales at predetermined times to avoid concerns about using material non-public information.

After completing the sale, Bonnell now owns 56,062 shares of ICU Medical, which is valued at approximately $9.5 million at the market close on September 1, 2026. Over the past year, ICU Medical's stock has delivered a 34% total return. While this share sale reduces Bonnell's individual direct ownership, total insider ownership at the company remains at 0.2% of shares outstanding.

ICU Medical specializes in developing, manufacturing, and selling medical devices for infusion therapy and critical care applications, generating the majority of its revenue. The company operates globally, serving acute care hospitals, dialysis facilities, and healthcare systems that require advanced infusion and critical care solutions.

ICU Medical's market capitalization stands at $4.3 billion as of August 31, 2026, and the company is positioned as a global medical technology leader with approximately 13,000 employees.